ValveXchange Inc

The emerging transcatheter aortic valve implantation (TAVI) device market is poised to become a future standard of care in patients deemed too high risk for open-heart surgery, with more than 50,000 i

As the number of hospitals taking on transcatheter aortic valve replacement (TAVR) procedures continues to grow, many of those providers are also considering building hybrid operating rooms (OR) and p

In Vitro Diagnostics Mergers & Acquisitions /In Vitro Diagnostics Astellas Pharma Inc. Cell Signaling Technology Inc. Pfizer Inc. Cell Signaling Technology Inc. (CST; research tools for identifyin

by Marie Gethins A record attendance of more than 13,100 cardiologists from around the globe gathered in Paris, France, this past May for the 2010 EuroPCR meeting, the official congress of the Europea